SpaceX’s spreads widened a fourth straight day — the $25 billion of 2036 paper, sold at 1.4 over Treasurys, now trades at 1.7 over, on “fatigue on heavy AI issuance” and too many fast-money holders looking for the door at once.
Set it next to the day’s binary-risk exhibit: AstraZeneca (AZN) fell 6.2% and Ionis (IONS) dropped 24% to $64.27 on a single failed heart trial. Add Paramount’s 8.43% bonds, and the pattern of the week is unmistakable.
Equity tells the story; credit tells the truth. A stock can rally on a narrative for a long time; a widening spread is a room full of professional lenders quietly deciding they want more to be paid for the same risk.
So SpaceX stays a watch, now with a credit tripwire. AZN and IONS stay avoided — we don’t hold coin flips in retirement money. And the boring alternative keeps working: SGOV reinforced at 4%+, zero drama, settles Tuesday.
SpaceX stays a watch, now with a credit tripwire: if spreads keep widening while the stock rallies, believe the spreads. AZN and IONS stay avoided — we don’t hold coin flips (a single failed trial took 24% of Ionis) in retirement money. The week’s lesson is structural: equity tells the story, credit tells the truth. The boring alternative keeps working — SGOV reinforced at 4%+, zero drama, settles Tuesday.